Post percutaneous coronary interventional adverse cardiovascular outcomes and bleeding events observed with prasugrel versus clopidogrel: direct comparison through a meta-analysis

Post percutaneous coronary interventional adverse cardiovascular outcomes and bleeding events observed with prasugrel versus clopidogrel: direct comparison through a meta-analysis

Abstract Background Due to limitations associated with clopidogrel following percutaneous coronary intervention (PCI), other newer oral anti-platelet agents are being studied. We aimed to systematically carry out a direct comparison of outcomes observed with prasugrel versus clopidogrel following PC...

Full description

Bibliographic Details
Main Authors: Pravesh Kumar Bundhun, Feng Huang
Format: Article
Language:English
Published: BMC 2018-05-01
Series:BMC Cardiovascular Disorders
Subjects:
Prasugrel
Clopidogrel
Percutaneous coronary intervention
Bleeding events
Major adverse cardiac events
Online Access:http://link.springer.com/article/10.1186/s12872-018-0820-6

Internet

http://link.springer.com/article/10.1186/s12872-018-0820-6

Similar Items